Literature DB >> 8438779

Essential fatty acids, plasma cholesterol, and fat-soluble vitamins in subjects with age-related maculopathy and matched control subjects.

T A Sanders1, A P Haines, R Wormald, L A Wright, O Obeid.   

Abstract

A matched-control study of plasma retinol, alpha-tocopherol, carotenoid, and cholesterol concentrations and the polyunsaturated fatty acid content of plasma and erythrocyte phospholipids was undertaken in 65 elderly patients with age-related maculopathy and 65 control subjects matched for age and sex. Despite the high statistical power of the study and large variations between subjects in the variables under consideration, no significant differences were noted between patients and control subjects. However, several statistically significant differences were noted between male and female subjects independent of their classification with maculopathy or as controls and age: plasma cholesterol, total phospholipids, alpha-tocopherol, and beta-cryptoxanthin concentrations were higher in females than in males. The mean plasma cholesterol concentration for the upper tertile of the whole sample was 7.6 mmol/L. Plasma concentrations of total carotenoids, alpha-carotene, and beta-carotene, but not alpha-tocopherol, were significantly lower in smokers than in non-smokers. The results of this study do not provide any evidence in favor of changing the dietary intake of polyunsaturated fatty acids or fat-soluble vitamins to protect against age-related maculopathy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8438779     DOI: 10.1093/ajcn/57.3.428

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  12 in total

1.  Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3.

Authors: 
Journal:  Ophthalmology       Date:  2000-12       Impact factor: 12.079

Review 2.  Epidemiology of age-related maculopathy: a review.

Authors:  Redmer van Leeuwen; Caroline C W Klaver; Johannes R Vingerling; Albert Hofman; Paulus T V M de Jong
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

Review 3.  Plasma apolipoproteins and risk for age related maculopathy.

Authors:  N Dashti; G McGwin; C Owsley; C A Curcio
Journal:  Br J Ophthalmol       Date:  2006-05-24       Impact factor: 4.638

Review 4.  Nutritional modulation of age-related macular degeneration.

Authors:  Karen A Weikel; Chung-Jung Chiu; Allen Taylor
Journal:  Mol Aspects Med       Date:  2012-04-06

5.  Does smoking influence the type of age related macular degeneration causing visual impairment?

Authors:  S S Dandekar; S A Jenkins; T Peto; A C Bird; A R Webster
Journal:  Br J Ophthalmol       Date:  2006-04-05       Impact factor: 4.638

6.  Role of long-chain and very-long-chain polyunsaturated fatty acids in macular degenerations and dystrophies.

Authors:  Aihua Liu; Yanhua Lin; Ryan Terry; Kelly Nelson; Paul S Bernstein
Journal:  Clin Lipidol       Date:  2011

7.  Retina and omega-3.

Authors:  Giuseppe Querques; Raimondo Forte; Eric H Souied
Journal:  J Nutr Metab       Date:  2011-10-31

Review 8.  Diminishing risk for age-related macular degeneration with nutrition: a current view.

Authors:  Molly Schleicher; Karen Weikel; Caren Garber; Allen Taylor
Journal:  Nutrients       Date:  2013-07-02       Impact factor: 5.717

9.  Elevated high-density lipoprotein cholesterol and age-related macular degeneration: the Alienor study.

Authors:  Audrey Cougnard-Grégoire; Marie-Noëlle Delyfer; Jean-François Korobelnik; Marie-Bénédicte Rougier; Mélanie Le Goff; Jean-François Dartigues; Pascale Barberger-Gateau; Cécile Delcourt
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

10.  The role of the carotenoids, lutein and zeaxanthin, in protecting against age-related macular degeneration: a review based on controversial evidence.

Authors:  Maneli Mozaffarieh; Stefan Sacu; Andreas Wedrich
Journal:  Nutr J       Date:  2003-12-11       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.